| 今开：22.6 | 昨收：22.66 |
| 最高：23.03 | 最低：22.56 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：2.388701293E9 |
产业链观察01-02 21:50
#药闻简讯# 制药商 $Corcept医疗(CORT)$ 股价在输掉针对$梯瓦制药(TEVA)$ 的专利诉讼后下跌了近 35%
这起诉讼与治疗库欣综合征的药物Korlym有关。查看全文
Corcept Therapeutics(CORT)04-19 05:15
$Corcept Therapeutics(CORT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-100927 Act: 34 Size: 13 KB 网页链接查看全文
丰硕创投04-17 17:46
$Corcept Therapeutics(CORT)$ 2024年1月2日，Corcept公司的糖皮质激素受体拮抗剂Korlym®（米非司酮），乃FDA首个批准用于治疗库欣综合征的药物，法院裁决Teva制药公司不侵犯该司专利号10195214和10842800。查看全文
Corcept Therapeutics(CORT)04-17 18:15
$Corcept Therapeutics(CORT)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-24-098492 Act: 34 Size: 144 KB 网页链接查看全文
Corcept Therapeutics(CORT)04-13 07:05
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-044185 Size: 12 KB 网页链接查看全文
Corcept Therapeutics(CORT)04-18 04:55
$Corcept Therapeutics(CORT)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-016598 Act: 34 Size: 11 MB 网页链接查看全文
Corcept Therapeutics(CORT)04-05 00:45
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000010 Act: 33 Size: 5 KB 网页链接查看全文
Corcept Therapeutics(CORT)04-11 04:45
$Corcept Therapeutics(CORT)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-015633 Act: 34 Size: 3 MB 网页链接查看全文
Corcept Therapeutics(CORT)04-09 06:25
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042725 Size: 9 KB 网页链接查看全文
Corcept Therapeutics(CORT)04-04 08:05
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041450 Size: 8 KB 网页链接查看全文
$Corcept Therapeutics(CORT)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-100927 Act: 34 Size: 13 KB 网页链接
$Corcept Therapeutics(CORT)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-016598 Act: 34 Size: 11 MB 网页链接
$Corcept Therapeutics(CORT)$ 8-K Current report, items 1.01, 2.03, and 9.01 Accession Number: 0001193125-24-098492 Act: 34 Size: 144 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-044185 Size: 12 KB 网页链接
$Corcept Therapeutics(CORT)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-015633 Act: 34 Size: 3 MB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-042725 Size: 9 KB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001973251-24-000010 Act: 33 Size: 5 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041450 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041435 Size: 8 KB 网页链接
$Corcept Therapeutics(CORT)$ 144 Report of proposed sale of securities Accession Number: 0001959173-24-002675 Act: 33 Size: 6 KB 网页链接